Clinical trial
Resting Heart Rate Monitoring for Optimized Treatment and Surveillance of Hyperthyroidism
NCT04932135 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Resting Heart Rate Monitoring for Optimized Treatment and Surveillance of Hyperthyroidism
- Lead sponsor
- University Hospital, Basel, Switzerland
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 8, 2021
- Completion date
- October 30, 2023
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.